Product Information
OVIDREL 250 MCG/0.5 ML SYRG is a brand product labeled by EMD Serono, Inc., priced at $485.4320 per ML under NDC 44087115001. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
250 ug/.5mL
Manufacturer
EMD Serono, Inc.NDC
44087115001
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
CHORIOGONADOTROPIN ALFAApproval Type
Biologic (BLA)
FDA Application
BLA021149On Market Since
10/6/2003
Pharmacological Classes
Price Statistics
The NADAC for OVIDREL 250 MCG/0.5 ML SYRG has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 150.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $485.4320 per ML |
|---|---|
| All-time high | $489.3800 (Jul 16, 2025) |
| All-time low | $193.9320 (Nov 28, 2013) |
| 52-week high | $487.3564 |
| 52-week low | $485.3285 |
| Median price | $342.6369 |
| Average price | $346.7977 |
| Largest weekly change | +14.0% (Jan 29, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the choriogonadotropin alfa market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
EMD Serono, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
choriogonadotropin alfa market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OVIDREL 250 MCG/0.5 ML SYRG?
The current National Average Drug Acquisition Cost (NADAC) for OVIDREL 250 MCG/0.5 ML SYRG, manufactured by EMD Serono, Inc., is $485.4320 per ML (NDC 44087115001), effective Sep 30, 2026.
How has the price of OVIDREL 250 MCG/0.5 ML SYRG changed over time?
Over the history we have for it, the NADAC for OVIDREL 250 MCG/0.5 ML SYRG has risen 150.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OVIDREL 250 MCG/0.5 ML SYRG?
Since Nov 28, 2013, the NADAC for OVIDREL 250 MCG/0.5 ML SYRG has ranged from a low of $193.9320 (Nov 28, 2013) to a high of $489.3800 (Jul 16, 2025), with a median of $342.6369 per ML.
Are there cheaper alternatives to OVIDREL 250 MCG/0.5 ML SYRG?
No other NADAC-published product currently shares the active ingredient and strength of OVIDREL 250 MCG/0.5 ML SYRG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OVIDREL 250 MCG/0.5 ML SYRG?
OVIDREL 250 MCG/0.5 ML SYRG (NDC 44087115001) is labeled by EMD Serono, Inc., and CMS classifies it as a brand product.